Does the nicotine metabolite ratio moderate smoking cessation treatment outcomes in real‐world settings? A prospective study

BACKGROUND AND AIMS: In smoking treatment trials comparing varenicline with transdermal nicotine replacement therapy (NRT), stratified by nicotine metabolite (3‐hydroxycotinine/cotinine) ratio (NMR), the relative benefit of varenicline is greater among normal rather than slow metabolizers. This stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahab, Lion, Bauld, Linda, McNeill, Ann, Tyndale, Rachel F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6492100/
https://www.ncbi.nlm.nih.gov/pubmed/30276911
http://dx.doi.org/10.1111/add.14450

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6492100/
https://www.ncbi.nlm.nih.gov/pubmed/30276911
http://dx.doi.org/10.1111/add.14450

Ejemplares similares